Silver Oak Securities Incorporated Takes $268,000 Position in Masimo Corporation (NASDAQ:MASI)

Silver Oak Securities Incorporated bought a new position in Masimo Corporation (NASDAQ:MASI - Free Report) in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 1,638 shares of the medical equipment provider's stock, valued at approximately $268,000.

Several other institutional investors and hedge funds have also recently bought and sold shares of MASI. Jones Financial Companies Lllp bought a new stake in Masimo during the 4th quarter valued at $27,000. Farther Finance Advisors LLC raised its stake in shares of Masimo by 128.9% during the first quarter. Farther Finance Advisors LLC now owns 206 shares of the medical equipment provider's stock valued at $35,000 after purchasing an additional 116 shares in the last quarter. EverSource Wealth Advisors LLC lifted its holdings in Masimo by 40.0% in the fourth quarter. EverSource Wealth Advisors LLC now owns 224 shares of the medical equipment provider's stock worth $37,000 after purchasing an additional 64 shares during the period. Smartleaf Asset Management LLC lifted its holdings in Masimo by 31.6% in the fourth quarter. Smartleaf Asset Management LLC now owns 250 shares of the medical equipment provider's stock worth $42,000 after purchasing an additional 60 shares during the period. Finally, SBI Securities Co. Ltd. bought a new position in Masimo in the 4th quarter valued at about $46,000. Institutional investors own 85.96% of the company's stock.

Insiders Place Their Bets

In other Masimo news, COO Bilal Muhsin sold 10,000 shares of Masimo stock in a transaction that occurred on Monday, May 12th. The shares were sold at an average price of $163.28, for a total transaction of $1,632,800.00. Following the transaction, the chief operating officer directly owned 24,172 shares in the company, valued at approximately $3,946,804.16. The trade was a 29.26% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 9.70% of the company's stock.

Masimo Price Performance

Masimo stock traded up $1.96 during mid-day trading on Tuesday, hitting $164.41. The company's stock had a trading volume of 34,073 shares, compared to its average volume of 637,711. The company has a quick ratio of 1.62, a current ratio of 2.17 and a debt-to-equity ratio of 0.67. The stock has a market capitalization of $8.91 billion, a P/E ratio of -17.92 and a beta of 1.19. Masimo Corporation has a twelve month low of $101.61 and a twelve month high of $194.88. The stock's fifty day moving average price is $161.86 and its two-hundred day moving average price is $166.39.

Masimo (NASDAQ:MASI - Get Free Report) last issued its earnings results on Tuesday, May 6th. The medical equipment provider reported $1.36 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.24 by $0.12. The business had revenue of $372.00 million for the quarter, compared to analysts' expectations of $367.79 million. Masimo had a positive return on equity of 22.56% and a negative net margin of 25.06%. The company's quarterly revenue was down 24.5% on a year-over-year basis. During the same period in the previous year, the firm posted $0.77 EPS. Research analysts forecast that Masimo Corporation will post 4.1 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several research firms have commented on MASI. Needham & Company LLC reissued a "hold" rating on shares of Masimo in a research note on Thursday, April 10th. BTIG Research set a $193.00 price objective on shares of Masimo and gave the company a "buy" rating in a research note on Wednesday, May 7th. Wall Street Zen lowered shares of Masimo from a "buy" rating to a "hold" rating in a research note on Friday, May 30th. Raymond James Financial lowered their price target on Masimo from $204.00 to $185.00 and set an "outperform" rating on the stock in a research report on Wednesday, May 7th. Finally, Wells Fargo & Company lowered their price target on Masimo from $205.00 to $190.00 and set an "overweight" rating on the stock in a research report on Wednesday, May 7th. Two equities research analysts have rated the stock with a hold rating and five have given a buy rating to the company. Based on data from MarketBeat.com, Masimo currently has an average rating of "Moderate Buy" and an average target price of $191.60.

About Masimo

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.